The second-generation SAPIEN XT balloon-expandable valve was found to have a higher 5-year rate of structural valve deterioration compared with surgical aortic valve replacement.
Endocan level was found to be an independent predictor of the no-reflow phenomenon during primary percutaneous coronary intervention for STEMI.
Women with type 2 diabetes, but not prediabetes, may have a greater relative risk for prevalent cardiovascular disease than men.
Retrograde coronary venous ethanol ablation may prevent the recurrence of arrhythmias in the long-term in patients with ventricular arrhythmias refractory to drugs and radiofrequency ablation.
Valve-in-mitral annular calcification and valve-in-ring TMVR were found to be successful.
Elevated cardiac troponin I levels had prognostic value for paroxysmal supraventricular tachycardias only when the condition was associated with a history of coronary artery disease.
A combination of statin and ezetimibe vs statin alone was found to further reduce levels of LDL-C in patients at very high cardiovascular risk.
A novel pigtail/J-wire technique for crossing stenotic aortic valves was found to be rapid, simple, and safe to implement.
Active myocarditis stage was found to predict the recurrence of ventricular tachycardia (VT) in patients with myocarditis undergoing VT ablation.
Anti-inflammatory therapy with canakinumab was found to reduce the total number of cardiovascular events in patients with prior myocardial infarction and evidence of residual inflammatory risk.
